3 hours Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Recommendation of “Buy” from Analysts MarketBeat
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has received an average recommendation of “Buy” from the nine analysts that are covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and on…